Literature DB >> 27090798

Assessment of the frequency of genetic alterations (LOH/MSI) in patients with intraepithelial cervical lesions with HPV infection: a pilot study.

Monika Migdalska-Sęk1, Agata Karowicz-Bilińska2, Dorota Pastuszak-Lewandoska3, Karolina H Czarnecka3, Ewa Nawrot3, Daria Domańska-Senderowska3, Justyna Kiszałkiewicz3, Ewa Brzeziańska-Lasota3.   

Abstract

In the present study, we analyzed (1) the type of HPV infection and (2) the frequency of loss of heterozygosity and microsatellite imbalance (LOH/MSI) in normal cytology and cervical intraepithelial neoplasia (CIN1-3). The cytological material included: low-grade squamous intraepithelial lesions (CIN1, n = 11), high-grade lesions (CIN2 and CIN3, n = 13), and cytologically normal cells from non-neoplastic cervical samples (n = 8). HPV genotyping was done using RealLine HPV 16/18 kit. We used 20 microsatellite markers from: 1p31.2, 3p14.3, 3p21.3, 3p22.2, 3p24.2, 3p25.3, 7q32.2, 9p21.3, 11p15.5, 12q23.2, and 16q22.1. LOH/MSI was correlated with clinicopathological parameters. The presence of HPV DNA was revealed in 78.13 % samples, including normal cytology. LOH/MSI was the most frequent for: 3p25.3 (39 %), 3p22.2 (20.83 %), 3p24.2 (20 %), and 3p14.3 (16.67 %). It was demonstrated that D3S1234 (FHIT; 3p14.3), D3S1611 (MLH1; 3p22.2), D3S1583 (RARB; 3p24.2), D3S1317 and D3S3611 (VHL; 3p25.3) could differentiate patients with CIN2/CIN3 versus CIN1, showing significantly higher frequency in CIN2/CIN3. LOH/MSI frequency for other than 3p markers was lower, 10-22.2 %. The simultaneous occurrence of LOH/MSI for several markers (OFAL) was higher in CIN2/CIN3. Significant differences in OFAL were found between samples with versus without HPV infection. In HPV-positive patients, significant differences in OFAL were found between normal cytology, CIN1 and CIN2/CIN3. HPV infection influences the increase in LOH/MSI frequency, especially in tumor suppressor gene loci. Several studied microsatellite markers seem to be useful for CIN grading. Hopefully, the obtained results, if confirmed on larger patient cohort, would allow creating a panel of markers supporting clinical diagnosis in patients with HPV infection.

Entities:  

Keywords:  Cervical intraepithelial neoplasia (CIN); HPV16/18; Loss of heterozygosity/microsatellite imbalance (LOH/MSI); Overall frequency of allelic loss (OFAL); Panel of markers

Mesh:

Year:  2016        PMID: 27090798     DOI: 10.1007/s12032-016-0763-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  37 in total

Review 1.  Epidemiology of human papillomavirus (HPV) infections and their associations with genital squamous cell cancer. Review article.

Authors:  K J Syrjänen
Journal:  APMIS       Date:  1989-11       Impact factor: 3.205

2.  Assessment of gene promoter hypermethylation for detection of cervical neoplasia.

Authors:  G Bea A Wisman; Esther R Nijhuis; Mohammad O Hoque; Nathalie Reesink-Peters; Alice J Koning; Haukeline H Volders; Henk J Buikema; H Marike Boezen; Harry Hollema; Ed Schuuring; David Sidransky; Ate G J van der Zee
Journal:  Int J Cancer       Date:  2006-10-15       Impact factor: 7.396

3.  Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas.

Authors:  C R Herzog; K A Crist; C L Sabourin; G J Kelloff; C W Boone; G D Stoner; M You
Journal:  Mol Carcinog       Date:  2001-03       Impact factor: 4.784

4.  Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix.

Authors:  A M Kersemaekers; M J van de Vijver; G G Kenter; G J Fleuren
Journal:  Genes Chromosomes Cancer       Date:  1999-12       Impact factor: 5.006

5.  FHIT alterations in cancerous and non-cancerous cervical epithelium.

Authors:  K Yoshino; T Enomoto; T Nakamura; H Sun; K Ozaki; R Nakashima; H Wada; J Saitoh; Y Watanabe; K Noda; Y Murata
Journal:  Int J Cancer       Date:  2000-01-01       Impact factor: 7.396

6.  HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.

Authors:  Dorota Pastuszak-Lewandoska; Anna Bartosińska-Dyc; Monika Migdalska-Sęk; Karolina H Czarnecka; Ewa Nawrot; Daria Domańska; Krzysztof Szyłło; Ewa Brzeziańska
Journal:  Med Oncol       Date:  2014-01-17       Impact factor: 3.064

7.  Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas.

Authors:  Vera Senchenko; Jian Liu; Eleonora Braga; Natalia Mazurenko; Witaly Loginov; Yury Seryogin; Igor Bazov; Alexei Protopopov; Fedor L Kisseljov; Vladimir Kashuba; Michael I Lerman; George Klein; Eugene R Zabarovsky
Journal:  Oncogene       Date:  2003-05-15       Impact factor: 9.867

Review 8.  The molecular genetics of cervical carcinoma.

Authors:  P A Lazo
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

9.  Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis.

Authors:  Adam Antczak; Monika Migdalska-Sęk; Dorota Pastuszak-Lewandoska; Karolina Czarnecka; Ewa Nawrot; Daria Domańska; Jacek Kordiak; Paweł Górski; Ewa Brzeziańska
Journal:  Med Oncol       Date:  2013-03-17       Impact factor: 3.064

10.  Loss of heterozygosity and copy number alterations in flow-sorted bulky cervical cancer.

Authors:  Sabrina A H M van den Tillaart; Wim E Corver; Dina Ruano Neto; Natalja T ter Haar; Jelle J Goeman; J Baptist M Z Trimbos; Gertjan J Fleuren; Jan Oosting
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more
  4 in total

1.  Analysis of diagnostic and prognostic value of lncRNA MEG3 in cervical cancer.

Authors:  Shuqiong Wan; Huanqiu Zhao
Journal:  Oncol Lett       Date:  2020-08-31       Impact factor: 2.967

2.  PISMA: A Visual Representation of Motif Distribution in DNA Sequences.

Authors:  Rogelio Alcántara-Silva; Moisés Alvarado-Hermida; Gibrán Díaz-Contreras; Martha Sánchez-Barrios; Samantha Carrera; Silvia Carolina Galván
Journal:  Bioinform Biol Insights       Date:  2017-03-30

3.  Study on the correlation between hTREC and HPV load and cervical CINI/II/III lesions and cervical cancer.

Authors:  Haizhen He; Qionghui Pan; Jiajia Pan; Yumei Chen; Liqin Cao
Journal:  J Clin Lab Anal       Date:  2020-02-26       Impact factor: 2.352

4.  Investigation of Cervical Tumor Biopsies for Chromosomal Loss of Heterozygosity (LOH) and Microsatellite Instability (MSI) at the HLA II Locus in HIV-1/HPV Co-infected Women.

Authors:  Ramadhani Chambuso; Evelyn Kaambo; Lynette Denny; Clive M Gray; Anna-Lise Williamson; Monika Migdalska-Sęk; Gloudi Agenbag; George Rebello; Raj Ramesar
Journal:  Front Oncol       Date:  2019-10-15       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.